INTRODUCTION
Acyl-CoA-binding protein (ACBP) was first described by Mogensen et al. (1987) . The protein was identified by its ability to bind acyl-CoA and to induce medium-chain acyl-CoA synthesis by goat mammary-gland fatty acid synthetase. When ACBP from bovine and rat liver was sequenced (Mikkelsen et al., 1987; Knudsen et al., 1989) , it turned out to be identical with diazepam-binding inhibitor . Diazepambinding inhibitor was first isolated from rat brain and identified by its ability to displace diazepam from the benzodiazepinebinding site on the y-aminobutyric acid receptor complex (GABAA) . The same protein was later isolated from bovine brain and given the name endozepine (Shoyab et al., 1986) . These groups conclude that ACBP (diazepam-binding inhibitor) is a natural modulator of GABA stimulation of the GABAA complex . Recent studies have indicated that this protein might also be involved in steroid-hormone synthesis (Besman et al., 1989; Papadopoulos et al., 1991) and regulation of glucose-induced insulin secretion (Ostenson et al., 1990) .
The function of ACBP as a modulator of the GABAA receptor complex has been questioned (Knudsen and Nielsen, 1990) . The main arguments against ACBP being a natural modulator of GABA stimulation are that, in the original work , large concentrations (in the micromolar range) were needed to displace benzodiazepines from GABAA, and that these results could not be repeated with ACBP purified from bovine liver (Knudsen and Nielsen, 1990) . Direct binding of ACBP to the GABAA receptor has never been shown. Furthermore, ACBP is present in all tissues tested, with the highest concentration being found in the liver (Mikkelsen et al., 1987; Knudsen et al., 1989; Bovolin et al., 1990) , and finally recent results obtained by in vitro hybridization indicate that ACBP is only expressed at a very low level in neurons (Tong et al., 1991) .
A role of ACBP in the acute regulation of steroid-hormone secretion, as previously suggested by Yanagibashi et al. (1988) and Besman et al. (1989) luteinizing hormone (Brown et al., 1992) . Furthermore, the increase in plasma corticosterone level after adrenocorticotropin replacement in hypophysectomized rats precedes the increase in ACBP in the adrenal gland (Massotti et al., 1991) .
There are several indications that ACBP functions as an intracellular acyl-CoA transporter and acyl-CoA pool former. ACBP binds acyl-CoA esters with high affinity in vitro (Mikkelsen et al., 1987; Knudsen et al., 1989) , it can compete with other cell proteins and membranes in binding acyl-CoA in vitro (Rasmussen et al., 1990) and it has been possible to bind and photocross-link a photoreactive radioactive acyl-CoA derivative to ACBP (Hach et al., 1990) .
If ACBP functions as an intracellular acyl-CoA transporter and acyl-CoA-pool former, it can be predicted that overexpression of ACBP in a given cell would result in an increased intracellular pool size of acyl-CoA. To test this hypothesis, a bovine synthetic ACBP gene was expressed in yeast (Saccharomyces cerevisiae). The results from these in vivo experiments show that a high-level expression of ACBP has the expected effect on the acyl-CoA level, supporting the hypothesis that ACBP is an intracellular acyl-CoA transporter and pool former.
MATERIALS AND METHODS Materials
Yeast nitrogen base (without amino acids) was from Difco Laboratories, Detroit, MI, U.S.A. Q-Sepharose fastflow and Sephadex G-50 superfine were obtained from Pharmacia Biosystem, Uppsala, Sweden. Nucleosil ODS (10 ,um particle size, 100 nm pore size) and Nucleosil ODS (10 utm particle size, 300 nm pore size) were from Machery-Nagel, Diiren, Germany. 3, leu 2-112, ura3-52, pep4-del-2:: LEU 2) was kindly supplied by Morten Kielland Brandt, Carlsberg Laboratory, Copenhagen, Denmark. The pCGS109 vector (Botstein et al., 1987) (Johnston and Davis, 1984) at nucleotide 819, and the EcoRI-BamHI fragment containing the entire promoter was inserted between the EcoRI and BamHI sites of pCGS40 (Goff et al., 1984) .
The E. coli strain used for propagation of plasmids was DH5aX (F-, recAl, endAl, gyrA96, thi, hsdRJ7 (rK-, mK'), sup E44, relAl, A-D 80 dlac 2 A M15).
Growth media Growth media for yeast transformed with the expression plasmids and used for production of recombinant bovine ACBP were composed as follows: 5 litres of medium contained 50 g of succinate, 30 g of NaOH, 10 g of(NH4)2HP04, 1.25 g of K2HPO4, 8.75 g of KH2PO4, 5 g of MgSO4, 7 H20, 1 g of NaCl, 1.05 g of CaCl2, 200 mg ofarginine, histidine and adenine sulphate, 300 mg of valine, tryptophan, leucine, isoleucine, lysine and tyrosine, 500 mg of phenylalanine, 600 mg of methionine, 1 g of glutamic acid, 37.5 g serine, 3 g of aspartic acid, 6 g of threonine, 200 g of galactose, 100 ,ul of each of the solutions 0.1 %0 H3B03, 0.1 0 CuSO4, 0.1% KI, 0.5%, FeC13 and 0.7 0SO ZnSO4 and 10 ml of vitamin stock solution containing 0.2 mg of biotin, 40 mg of thiamine, pyridoxine and calcium pantothenate and 200 mg of inositol/100 ml.
Growth media for cultures used for determination of growth curves, acyl-CoA and ACBP content contained 6.7 g/l yeast nitrogen base (without amino acids), 20 g/l galactose, 20 mg/l histidine and 30 mg/l leucine. Cultures (500 ml) were grown with shaking in 5-litre conical flasks at 30 'C.
Construction of pCGS109ACBP and pCGS109ACBP-T To make pCGS109ACBP (Figure la) , the synthetic bovine ACBP gene was excised as a 288 bp EcoRI-Sall fragment from pUC19ACBP and cloned between the BamHI and SalI sites of pCGS109.
The plasmid pCGS109ACBP-T (Figure lb) contains the yeast TRPI terminator inserted immediately 3' of the ACBP gene. To make this construct, the terminator (Zaret and Sherman, 1982) was excised from the TRPJ gene as a HindIII-BglII fragment (nucleotide 615-852; Tschumper and Carbon, 1980) and inserted in pBluescript KS( +) (Stratagene). The HindIII-Xbal fragment containing the TRP1 terminator was excised and inserted between the BamHI and XbaI sites in pUC19ACBP to make pUC19ACBP-T. Subsequently, the EcoRI-Sall fragment of this plasmid containing the ACBP gene and the TRPI terminator was cloned between the BamHI and Sall sites of pCGS109.
All plasmid constructions were propagated in the E. coli strain DH5a. The yeast strain JHRY 20-2C-del-2 was then transformed with the two expre-ssion plasmids as described by Ito et al. (1983) .
Puriication of recombinant bovine ACBP Cells grown to a density of A550 = 17.5 in a 5-litre fermenter with automatic pH control were harvested by centrifugation at 3000 g for 30 min. The pelleted cells were washed with 0.5 vol. of 0.9 % (w/v) NaCl and repelleted.
The repelleted cells were resuspended in 1 M acetic acid using a volume equal to that of the cells and passed twice through a French press at a pressure of 3450 kPa. The resulting pH was 3.5-4.0. The pH was then adjusted to 7.0 with 5 M NaOH and the solution cleared by centrifugation at I04 g for 20 min. The pellet was discarded and the supernatant was heated at 50°C for 20 min, placed on ice and cleared by centrifugation at 104g for 20 min. The supernatant was then loaded on to a Sephadex G-50 superfine column (5 cm x 80 cm) equilibrated with 30 mM Tris/HCl, pH 9.0, 0.02 % (w/v) sodium azide. The proteins were eluted with the same buffer with a flow of 80 ml/h. The ACBPcontaining fractions were loaded on a Q Sepharose fast-flow ionexchange column (2.5 cm x 32 cm) equilibrated with 30 mM Tris/HCl, pH 9.0 (buffer A). The proteins were eluted with a gradient of 0.5 M NaCl in 30 mM Tris/HCl, pH 9.0 (buffer B). The gradient of buffer B in A was as follows: 0-10 % B in 10 min, 10-20 % B in 40 min, 20-35 %O B in 80 min.
The ACBP-containing fraction from the ion-exchange column was pooled and further purified by reversed-phase h.p.l.c. on a Nucleosil ODS 10/100 C18 column (8 mm Characterization of recombinant ACBP The structure of ACBP was verified by SAP and trypsin digestion followed by analysis by plasma desorption m.s. as previously described (Mikkelsen et al., 1987) .
Protein determination Total protein was determinated by a modified Lowry method described by Schachterle and Pollack (1973) . ACBP concentrations in solutions of pure ACBP were determined by u.v. absorption using A°280 -15.5. Electrophoresis SDS/PAGE was carried out on 20 % (w/v) homogeneous gels in the Pharmacia Phast System using the conditions recommended by the manufacturer.
Determination of bovine ACBP content in yeast by eJ.i.s.a.
Yeast cells (2 x 108) were harvested by centrifugation at 3000 g for 10 min and washed with 1 ml of 0.9 % (w/v) KCI. The cells were resuspended in 600 ul of 1.0 mM phenylmethanesulphonyl
The suspension was vortexed (6 x 30 s with intermittent cooling on ice). The supernatant was transferred to an Eppendorf tube and cleared by centrifugation at 18 000 g for 1 min. Samples were taken for protein and ACBP determination and stored at -80°C until analysis could be performed. It was routinely checked that more than 90 % of the cells were broken by this procedure.
Determinations of total soluble protein and ACBP by e.l.i.s.a. were as described previously (Hansen et al., 1991) , except that rabbit anti-(bovine ACBP) and biotinylated rabbit anti-(bovine ACBP) antibodies were used.
Extraction and reversed-phase h.p.l.c. of acyl-CoA esters Yeast cells (approx. 5 x 109) were harvested by centrifugation at 3000 g for 15 min and resuspended in water to a final volume of 0.8 ml. The suspension was transferred to a -80°C precooled Eton Press and extruded through a 1 mm hole by applying a high pressure on the piston. The frozen extruded yeast suspension was quantitatively transferred to a precooled 25 ml glass centrifuge tube. Acyl-CoA esters were extracted and analysed by reversedphase h.p.l.c. as described by Rosendal and 
RESULTS AND DISCUSSIONS Construction of expression plasmids
A synthetic gene encoding the 86 amino acid residues of mature bovine ACBP and the initiating methionine residue was constructed and expressed in E. coli . The codon usage and the sequences flanking the coding region were designed in such a way that transcripts from the gene would be efficiently translated not only in E. coli but also in S. cerevisiae.
Thus, this synthetic gene was transferred to the yeast expression vector pCGS 109. Two constructs were made, pCGS109ACBP and pCGS109ACBP-T (Figure 1 ). In both of these, transcription of the ACBP gene is driven by the galactose-inducible GAL] promoter giving rise to transcripts with a 5'-leader of approx. 60 nt which contains no alternative AUG start codons. In pCGS109ACBP, the synthetic ACBP gene was inserted between fluoride, and 600 #1 of dry glass pearls (0.25-0.3 mm) was added. (Zaret and Sherman, 1982) and transcripts from the GAL] promoter in pCGS109ACBP most probably terminate at the URA3 terminator. The stability of mRNA in yeast has been reported to decrease with increasing length of the mRNA (Brown et al., 1988) . Thus, in order to possibly increase the stability of the ACBP mRNA, we constructed pCGS109ACBP-T where the TRPI terminator was inserted immediately 3' of the synthetic ACBP gene.
Expression of bovine ACBP in yeast
The GALI promoter is tightly regulated (Johnston and Davis, 1984; Yocum et al., 1984) , and we were unable to detect any bovine ACBP in transformed yeast cells grown in the absence of galactose (results not shown). However, addition of galactose (20 g/l) to the growth medium resulted in a large induction of ACBP synthesis. In maximally induced exponentially growing cells containing the pCGS109ACBP or the pCGS109ACBP-T vector, bovine ACBP constitutes 1.8 % and 6.4 % of total soluble protein respectively. This indicates that insertion of the TRPI terminator, as expected, resulted in an increased stability of the ACBP transcript.
The high-level expression of bovine ACBP in yeast did not affect the growth rate when compared with control cells transformed with the vector without the ACBP gene inserted (Figure 2 ). This indicates that expression of bovine ACBP did not significantly affect the energy metabolism of the cells.
The expressed bovine ACBP was purified and the sequence was confirmed by peptide mapping with SAP followed by determination of the Mr of each individual peptide (Table 1 ). The
Mr of the N-terminal SAP peptide could not be obtained. In order to confirm the primary structure of this part of the molecule, the protein was subjected to tryptic digestion and the mass of the N-terminal tryptic peptide (Tl) was determined. The observed values of Mr deviated by no more than 0.14 % from the expected values calculated from the sequence of bovine ACBP (Mikkelsen et al., 1987) (Table 1 ). The Mr obtained for the intact protein was 9955.9 which is in good agreement with the Mr calculated from the sequence (9955.3) (Mikkelsen et al., 1987) . The Mr of the intact protein and the N-terminal tryptic peptide clearly showed that the processing of ACBP in yeast is identical with that of native bovine ACBP, i.e. the initiating methionine is removed and the following serine residue is N-acetylated. In contrast, when recombinant bovine ACBP is expressed in E. coli, the initiating methionine is removed but less than 5% of the following serine residue is N-acetylated P. H0jrup, unpublished work) . The acyl-CoA concentrations of cells expressing bovine ACBP (i.e. those transformed with pCGS109ACBP or pCGS109ACBP-T) were compared with the acyl-CoA concentrations of cells containing only the expression vector pCGS109. Expression of bovine ACBP in yeast resulted in a significant increase in the cellular acyl-CoA pool, and there was a positive correlation between the size of this increase and the level of ACBP expression (Table 2 ). The results shown in Table 2 are typical of results obtained in three individual experiments.
As the acyl-CoA synthetase (Suzue and Marcel, 1972; Oram et al., 1975) and the yeast fatty acid synthetase (Lust and Lynen, 1968) are product-inhibited, the only possible interpretation of these data is that ACBP, by binding acyl-CoA, relieves the product inhibition of these two enzymes and thereby induces increased synthesis of acyl-CoA. The binding stoichiometry has previously been found to be 1 mol of acyl-CoA/mol of ACBP (Rasmussen et al., 1990) .
The main products of the yeast acyl-CoA synthetase are C16:0 and C18:0 acyl-CoA (Ratledge and Evans, 1989 (Rasmussen et al., 1990) . These data, together with the results obtained in the present work, strongly indicate that ACBP in vivo protects the above-mentioned functions from being inhibited by acyl-CoA esters.
ACBP could therefore play a triple role in the cell in (1) creating an acyl-CoA pool, (2) protecting membranes, transport functions and enzymes and (3) protecting acyl-CoA esters from being hydrolysed by long-chain acyl-CoA hydrolases which are found in high concentration in the liver cytosol and microsomes (Berge, 1979; Berge and Farstad, 1979; Berge et al., 1984 (Bovolin et al., 1990) , indicating that ACBP may be associated with such processes.
Acyl-CoA esters (probably used for protein acylation) have recently been shown to be obligatory for the budding off of transport vesicles in Golgi membranes as well as for the fusion of these vesicles with their acceptor membranes in the Golgi apparatus (Pfanner et al., 1989 (Pfanner et al., , 1990 . ACBP may be involved in delivering acyl-CoA esters for this purpose.
In summary, the present work gives conclusive evidence that the physiological function of ACBP is related to acyl-CoA metabolism. The ability of ACBP to function as an acyl-CoA pool former in vivo is in accordance with the detection of ACBP transcripts (Mochetti et al., 1986; Gray et al., 1986) and protein (Mikkelsen et al., 1987; Shoyab et al., 1986; Knudsen et al., 1989; Bovolin et al., 1990; Alho et al., 1991) (Mandrup et al., 1992) . The claimed functions of ACBP in the regulation of steroidogenesis (Bessman et al., 1989; Papadopoulos et al., 1991) , in the modulation of the GABAA receptors and in the inhibition of glucose-induced insulin secretion (Ostenson et al., 1990) do not require that ACBP should be widely expressed. Furthermore, these claimed functions do not explain why the expression of ACBP should be significantly increased on induction of preadipocyte-to-adipocyte differentiation of 3T3-L1 cells, as we have shown previously (Hansen et al., 1991) . Thus, although we cannot exclude the possibility that ACBP executes specific tasks in specialized cells, there seems to be no doubt that it is primarily a housekeeping protein, functioning as an acyl-CoA pool former and transporter.
